26 March 2014
Scientists in Novosibirsk are seeking a Russian Scientific Fund grant in an effort to create a cell bank—a key to faster identification of most working therapies for a variety of human diseases, Nanonewsnet.ru reported , citing Academician Valentin Vlasov, the director of the local Institute of Chemical Biology and Fundamental Medicine.
According to the scientist, the future bank will store cells taken primarily from people suffering from central nervous system disorders, including Alzheimer’s and Parkinson patients.
Researchers will use the cells to develop what he said would be models simulating the clinical course of such diseases, and to come up with appropriate solutions to successfully treat the disorders.
Acad. Vlasov further said the project will be joined by a number of other research entities, such as the Meshalkin Novosibirsk Research Institute of Circulatory Pathologies. He stopped short of specifying any timeframe for the biobank project, though.
“We will see later this year whether we win a tender or we don’t,” Mr. Vlasov concluded.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024